BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33720039)

  • 1. Plasma cells promote osteoclastogenesis and periarticular bone loss in autoimmune arthritis.
    Komatsu N; Win S; Yan M; Huynh NC; Sawa S; Tsukasaki M; Terashima A; Pluemsakunthai W; Kollias G; Nakashima T; Takayanagi H
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
    Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
    J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
    Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
    J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
    Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
    Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B1a cells play a pathogenic role in the development of autoimmune arthritis.
    Deng J; Wang X; Chen Q; Sun X; Xiao F; Ko KH; Zhang M; Lu L
    Oncotarget; 2016 Apr; 7(15):19299-311. PubMed ID: 27014914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas/S1P
    Hutami IR; Izawa T; Mino-Oka A; Shinohara T; Mori H; Iwasa A; Tanaka E
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1274-1281. PubMed ID: 28687489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bub1 suppresses inflammatory arthritis-associated bone loss in mice through inhibition of TNFα-mediated osteoclastogenesis.
    Yoshida S; Ikedo A; Yanagihara Y; Sakaue T; Saeki N; Imai Y
    J Bone Miner Res; 2024 Apr; 39(3):341-356. PubMed ID: 38477771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
    Chen Y; Wang X; Yang M; Ruan W; Wei W; Gu D; Wang J; Guo X; Guo L; Yuan Y
    Med Sci Monit; 2018 Jul; 24():5292-5300. PubMed ID: 30059491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
    Kassem A; Lindholm C; Lerner UH
    PLoS One; 2016; 11(6):e0156708. PubMed ID: 27311019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.
    Danks L; Komatsu N; Guerrini MM; Sawa S; Armaka M; Kollias G; Nakashima T; Takayanagi H
    Ann Rheum Dis; 2016 Jun; 75(6):1187-95. PubMed ID: 26025971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis.
    Li Y; Yang C; Jia K; Wang J; Wang J; Ming R; Xu T; Su X; Jing Y; Miao Y; Liu C; Lin N
    J Ethnopharmacol; 2022 Jan; 282():114602. PubMed ID: 34492323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
    J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
    Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K
    Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.
    O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF
    Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of RANKL by Memory B Cells: A Link Between B Cells and Bone Erosion in Rheumatoid Arthritis.
    Meednu N; Zhang H; Owen T; Sun W; Wang V; Cistrone C; Rangel-Moreno J; Xing L; Anolik JH
    Arthritis Rheumatol; 2016 Apr; 68(4):805-16. PubMed ID: 26554541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis.
    Kim HR; Kim KW; Kim BM; Lee KA; Lee SH
    Korean J Intern Med; 2019 Jan; 34(1):210-219. PubMed ID: 28286938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
    Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
    Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways.
    Li CH; Ma ZZ; Jian LL; Wang XY; Sun L; Liu XY; Yao ZQ; Zhao JX
    Int Immunopharmacol; 2021 Jan; 90():107219. PubMed ID: 33307512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.